Specific Topics in the Torch

The following IWMF Torch magazine articles have been selected by the IWMF Torch editor because they contain especially important and topical information for patients.

Amyloidosis – IgM-related

Torch 12.3 (June 2011) pp. 1-2. 10. Morie A. Gertz, MD
Torch 14.2 (April 2013) pp. 1-4. Giampaolo Merlini, MD

Torch 23.1 (January 2022) pp.1-5. Shayna Sarosiek, MD

Anemia
Torch 10.3 (July 2009) pp. 20-22. Sue Herms
Torch 15.3 (August 2014) pp. 11, 35. Morie A. Gertz, MD

Bing Neel Syndrome
Torch 23-2 (April 2022) Jorge J. Castillo, MD

Biosimilar Drugs
Torch 21.1 (April 2020) pp. 1-5. Sue Herms and Glenn Cantor, MD

CD Markers
Torch (Winter 2008) p. 3. Sue Herms

Clinical Trials
Torch 14.3 (October 2013) pp. 1-3, 40. Gwen L. Nichols, MD

Torch 21.4 (October 2020) pp. 1-4. Tom Hoffmann, MD

Cold Agglutinin Henolytic Anemia and Cyroglobulinemia
Torch 23.3 (July 2022) Morie A. Gertz, MD, MACP

Complications in WM
Torch (Summer 2008) pp. 1, 5, 14. Rafat Abonour, MD
Torch 15.1 (January 2014) pp. 1-3. Morie A. Gertz, MD

COVID-related
Torch 22.3 (July 2021) Pandemic Perspective from India, Jaya Mani, Bangalore

Cryoglobulinemia
Torch (Spring 2007) p. 8. Sue Herms

CXCR4 Mutations in WM
Torch 22.2 (April 2021) pp. 1-6. Steven Treon, MD

Dental Considerations
Torch 18.4 (October 2017) pp. 1-2, 26-28. Linda P. Nelson, DMD, DDS

Depression
Torch 24.1 (January 2023) pp. 1-6. Marshall E. Lewis, MD

Dermatology
Torch 11.1 (January 2010) p. 14. Julia S. Lehman, MD

Diagnosis
Torch 20.4 (October 2019) pp. 1-5. Janis Atkinson, MD
Torch (Fall 2008) pp. 3-5. Morie A. Gertz, MD

Epigenetics
Torch 11.3 (July 2010) pp. 1-2, 30-31. Sue Herms

Eye and Vision
Torch 21.3 (July 2020). pp 1-5. Maureen Hanley, OD
Torch 12.1 (January 2011) pp. 1-5. Maureen Hanley, OD

Familial WM
Torch 20.1 (January 2019) pp. 1-4. Mary McMaster, MD

Fatigue and Cancer Treatment
Torch 22.4 (October 2021) pp. 1-4. Rina S. Fox, PhD and Lisa M. Wu, PhD

Flow Cytometry
Torch (Fall 2007) pp. 3, 20. Sue Herms

Free Light Chain Testing
Torch 17.2 (April 2016) pp.1-4, 31. Neal Makens, MD

Hyperviscosity
Torch 13.1 (January 2012) pp. 1-2, 28-29. Shirley D’Sa, MD

Ibrutinib
Torch 17.3 (September 2016) pp. 1-4. Jeffrey V. Matous, MD French Translation

Immunotherapy
Torch 18.3 (July 2017) pp. 1-3. Stephen M. Ansell, MD, PhD

MGUS
Torch 21.1 (January 2020) pp. 1-6. Irene Ghobrial, MD
Torch 19.4 (October 2018) pp. 6-8. Robert A. Kyle, MD
Torch (Spring 2008) pp. 1, 18-19. Robert A. Kyle, MD

Mutation MYD88 L265P
Torch 13.2 (April 2012) pp. 1-2, 21. Steven P. Treon, MD

Nutrition
Torch 20.2 (April 2019) pp. 1-4. Stacy Kennedy

Torch 24.2 (April 2023) pp.17-18. IWMF Physical Wellness Group, Education Committee

Peripheral Neuropathy
Torch 20.3 (July 2019) pp.1-5. Tom Hoffmann, MD
Torch 11.2 (April 2010) pp. 1-4. Todd Levine, MD

Plasmapheresis
Torch 10.2 (April 2009) pp. 4-5. Marvin J. Stone, MD

Rituximab
Torch Fall 2008 pp. 9-11. Sue Herms
Torch 11.4 (October 2010) pp. 1-2, 34-35. David G. Maloney, MD

Second Opinion
Torch 14.2 (April 2013) p. 7. Morie A. Gertz, MD  * Article revised in 2022

Side Effects
Torch 15.3 (August 2014) pp. 1-3, 35. Jeffrey V. Matous, MD

Treatment of WM
Torch 16.2 (April 2015) pp. 1-4. (When to Treat) Stephen M. Ansell, MD, PhD

Torch 23.4 (October 2022) pp. 1-6. (Understanding Treatments) Jonas Paludo, MD
Torch 24.2 (April 2023) pp. 1-5. (Patient Preferences in Treatment) Josephine M.I Vos, MD and Karima Amaador, MD

Tumor Microenvironment in WM
Torch 22.1 (January 2021) pp. 1-5. Shahrzad Jalali, PhD

Visit to Local Oncologist and to WM Specialist
Torch 15.4 (November 2014) pp. 9-11. Morie A. Gertz, MD  * Article revised in 2022

Watch and Wait
Torch 14.3 (October 2013) pp. 20, 43. Morie A. Gertz, MD

WM Genomics and Treatment Choices
Torch 19.1 (January 2018) pp. 1-5. Steven P. Treon, MD, PhD, FRCP